Home
Providers
KSQ Therapeutics
KSQ Therapeutics
KSQ Therapeutics is a clinical-stage biotechnology company headquartered at 4 Maguire Road in Lexington, Massachusetts, founded in 2015 by pioneers of CRISPR screening and functional genomics. Its proprietary CRISPRomics platform runs genome-scale CRISPR/Cas9 functional genomic screens across cancer models and immune cell types to identify therapeutic targets that directly correlate genomic function to disease. The company applies those targets in two directions: CRISPR/Cas9-engineered tumor-infiltrating lymphocyte (eTIL) cell therapies, where a single gene is inactivated to increase the tumor-killing capacity of a patient's own T cells — KSQ-001EX (SOCS1 inactivated) and KSQ-004EX (SOCS1 and Regnase-1 inactivated) — and small molecules such as KSQ-4279, a first-in-class USP1 inhibitor for advanced solid tumors. KSQ has run broad discovery collaborations with Takeda, licensed cell-therapy technology with CRISPR Therapeutics, partnered manufacturing with CTMC, and sold multiple research-stage oncology programs to Ono Pharmaceutical. Investors include Flagship Pioneering, ARCH Venture Partners, Polaris Partners, Alexandria, Alpha Wave Global, Baillie Gifford, Invus, LG and Lilly Asia Ventures. KSQ Therapeutics runs no developer program and publishes no product API, developer portal, OpenAPI or API reference. The only machine-readable surfaces reachable without credentials are the WordPress REST content API behind ksqtx.com, an All in One SEO generated /llms.txt, and the open-source bioinformatics code in its public GitHub organization — all catalogued here.
KSQ Therapeutics publishes 8 APIs on the APIs.io network, including Press Releases API, Pages API, Media API, and 5 more. Tagged areas include Company, Biotechnology, Life Sciences, Therapeutics, and Oncology.
KSQ Therapeutics’ developer surface includes engineering blog, product news, support, authentication, CLI, and 25 more developer resources.
8 APIs
On this page
Kin Score
APIs 8
Pricing Plans 1
Rate Limits 1
Security Posture 2
Resources 30
apis.yml
5 Operational Transparency
Composite quality — 32.1/100 · thin
Contract Quality
10.7 / 21
Developer Ergonomics
5.7 / 17
Operational Transparency
0.6 / 11
Contract Governance
3.1 / 10
Regulatory Posture
3.2 / 15
Agent readiness — 38/100 · agent ready
Machine-Readable Contract
18 / 18
Agentic Access Contract
0 / 10
Documented Reversibility
0 / 6
MCP Server
0 / 12
Machine-Readable Auth
10 / 10
Idempotency
0 / 9
Stable Error Semantics
8 / 8
Request/Response Examples
0 / 7
Rate-Limit Signaling
7 / 7
Typed Event Surface
0 / 6
Agent Skills
5 / 5
Well-Known Catalog
0 / 4
Consent & Bot Identity
0 / 3
A2A Agent Card
0 / 8
Dry-Run / Simulate Mode
0 / 4
Individual APIs this provider publishes, each with its own machine-readable definition.
Scroll for all 8
Published pricing tiers and plan structures.
Documented rate limits and quota policies.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Agent Surfaces 2
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 5
Pagination, idempotency, versioning, errors, and events
Build 4
SDKs, sample code, and the tooling you integrate with
Access & Security 2
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 9
The organization behind the API
Scroll for all 9
Other 5
Properties that don't map to a standard resource type
Source (apis.yml)
aid: ksq-therapeutics
name: KSQ Therapeutics
description: 'KSQ Therapeutics is a clinical-stage biotechnology company headquartered at 4 Maguire Road in Lexington, Massachusetts,
founded in 2015 by pioneers of CRISPR screening and functional genomics. Its proprietary CRISPRomics platform runs genome-scale
CRISPR/Cas9 functional genomic screens across cancer models and immune cell types to identify therapeutic targets that directly
correlate genomic function to disease. The company applies those targets in two directions: CRISPR/Cas9-engineered tumor-infiltrating
lymphocyte (eTIL) cell therapies, where a single gene is inactivated to increase the tumor-killing capacity of a patient''s
own T cells — KSQ-001EX (SOCS1 inactivated) and KSQ-004EX (SOCS1 and Regnase-1 inactivated) — and small molecules such as
KSQ-4279, a first-in-class USP1 inhibitor for advanced solid tumors. KSQ has run broad discovery collaborations with Takeda,
licensed cell-therapy technology with CRISPR Therapeutics, partnered manufacturing with CTMC, and sold multiple research-stage
oncology programs to Ono Pharmaceutical. Investors include Flagship Pioneering, ARCH Venture Partners, Polaris Partners,
Alexandria, Alpha Wave Global, Baillie Gifford, Invus, LG and Lilly Asia Ventures. KSQ Therapeutics runs no developer program
and publishes no product API, developer portal, OpenAPI or API reference. The only machine-readable surfaces reachable without
credentials are the WordPress REST content API behind ksqtx.com, an All in One SEO generated /llms.txt, and the open-source
bioinformatics code in its public GitHub organization — all catalogued here.'
url: https://raw.githubusercontent.com/api-evangelist/ksq-therapeutics/refs/heads/main/apis.yml
image: https://ksqtx.com/wp-content/uploads/2024/02/KSQ-logo-color-RegTM.png
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment
specificationVersion: '0.23'
created: '2026-08-23'
modified: '2026-08-23'
tags:
- Company
- Biotechnology
- Life Sciences
- Therapeutics
- Oncology
- Genomics
- CRISPR
- Gene Editing
- Cell Therapy
- Clinical Stage
- Functional Genomics
- content-api
tags_raw:
- Company
- biotechnology
- life-sciences
- therapeutics
- oncology
- genomics
- crispr
- gene-editing
- cell-therapy
- clinical-stage
- functional-genomics
- content-api
apis:
- aid: ksq-therapeutics:ksq-therapeutics-press-releases-api
name: KSQ Therapeutics Press Releases API
description: The press_release custom post type behind ksqtx.com — the company news archive. 39 items were returned anonymously
on 2026-08-23 (X-WP-Total), spanning the Takeda and Ono collaborations, the CRISPR Therapeutics license agreement, the
KSQ-001EX / KSQ-004EX / KSQ-4279 IND clearances and first-patient-dosed announcements, and conference poster presentations.
This is content-management platform infrastructure, not a product KSQ markets.
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://ksqtx.com/wp-json
tags:
- press_release
tags_raw:
- press-releases
- news
x-origin: platform-default
x-origin-note: Provided by WordPress core REST API, not authored or marketed by KSQ Therapeutics.
properties:
- type: OpenAPI
url: openapi/ksq-therapeutics-press-releases-api-openapi.yml
- type: Authentication
url: authentication/ksq-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/ksq-therapeutics-problem-types.yml
- type: Conventions
url: conventions/ksq-therapeutics-conventions.yml
- type: DataModel
url: data-model/ksq-therapeutics-data-model.yml
- aid: ksq-therapeutics:ksq-therapeutics-pages-api
name: KSQ Therapeutics Pages API
description: WordPress page collection behind ksqtx.com — Home, About, Platform, Pipeline, Partners, News, Press Releases,
Careers and the Expanded Access Policy. 9 items on 2026-08-23. Bodies are Divi page-builder markup delivered as rendered
HTML.
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://ksqtx.com/wp-json
tags:
- pages
tags_raw:
- pages
x-origin: platform-default
properties:
- type: OpenAPI
url: openapi/ksq-therapeutics-pages-api-openapi.yml
- type: Authentication
url: authentication/ksq-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/ksq-therapeutics-problem-types.yml
- type: Conventions
url: conventions/ksq-therapeutics-conventions.yml
- type: DataModel
url: data-model/ksq-therapeutics-data-model.yml
- aid: ksq-therapeutics:ksq-therapeutics-media-api
name: KSQ Therapeutics Media API
description: WordPress media library — 235 attachments on 2026-08-23, including leadership and board headshots, pipeline
and platform graphics, poster PDFs and the homepage background video.
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://ksqtx.com/wp-json
tags:
- media
tags_raw:
- media
x-origin: platform-default
properties:
- type: OpenAPI
url: openapi/ksq-therapeutics-media-api-openapi.yml
- type: Authentication
url: authentication/ksq-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/ksq-therapeutics-problem-types.yml
- type: Conventions
url: conventions/ksq-therapeutics-conventions.yml
- type: DataModel
url: data-model/ksq-therapeutics-data-model.yml
- aid: ksq-therapeutics:ksq-therapeutics-search-api
name: KSQ Therapeutics Search API
description: Cross-type WordPress search over every REST-exposed post type. 48 results anonymously on 2026-08-23. Returns
lightweight {id, title, url, type, subtype} records.
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://ksqtx.com/wp-json
tags:
- search
tags_raw:
- search
x-origin: platform-default
properties:
- type: OpenAPI
url: openapi/ksq-therapeutics-search-api-openapi.yml
- type: Authentication
url: authentication/ksq-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/ksq-therapeutics-problem-types.yml
- type: Conventions
url: conventions/ksq-therapeutics-conventions.yml
- type: DataModel
url: data-model/ksq-therapeutics-data-model.yml
- aid: ksq-therapeutics:ksq-therapeutics-discovery-api
name: KSQ Therapeutics Discovery API
description: The WordPress REST route index, namespace index, registered post types, taxonomies and statuses. 349 routes
across 9 namespaces on 2026-08-23. This is the only machine-readable contract KSQ Therapeutics serves, and the source
every derived artifact in this repo was built from.
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://ksqtx.com/wp-json
tags:
- discovery
tags_raw:
- discovery
x-origin: platform-default
properties:
- type: OpenAPI
url: openapi/ksq-therapeutics-discovery-api-openapi.yml
- type: Authentication
url: authentication/ksq-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/ksq-therapeutics-problem-types.yml
- type: Conventions
url: conventions/ksq-therapeutics-conventions.yml
- type: DataModel
url: data-model/ksq-therapeutics-data-model.yml
- aid: ksq-therapeutics:ksq-therapeutics-taxonomy-api
name: KSQ Therapeutics Taxonomy API
description: Category and post_tag term collections. Registered and anonymously reachable; one category term ("Uncategorized",
5 posts) and zero tags on 2026-08-23.
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://ksqtx.com/wp-json
tags:
- taxonomy
tags_raw:
- taxonomy
x-origin: platform-default
properties:
- type: OpenAPI
url: openapi/ksq-therapeutics-taxonomy-api-openapi.yml
- type: Authentication
url: authentication/ksq-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/ksq-therapeutics-problem-types.yml
- type: Conventions
url: conventions/ksq-therapeutics-conventions.yml
- type: DataModel
url: data-model/ksq-therapeutics-data-model.yml
- aid: ksq-therapeutics:ksq-therapeutics-posts-api
name: KSQ Therapeutics Posts API
description: The core WordPress post collection. Registered and anonymously reachable, but empty on this deployment (X-WP-Total
0 on 2026-08-23) — KSQ publishes news through press_release instead.
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://ksqtx.com/wp-json
tags:
- posts
tags_raw:
- posts
x-origin: platform-default
properties:
- type: OpenAPI
url: openapi/ksq-therapeutics-posts-api-openapi.yml
- type: Authentication
url: authentication/ksq-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/ksq-therapeutics-problem-types.yml
- type: Conventions
url: conventions/ksq-therapeutics-conventions.yml
- type: DataModel
url: data-model/ksq-therapeutics-data-model.yml
- aid: ksq-therapeutics:ksq-therapeutics-oembed-api
name: KSQ Therapeutics oEmbed API
description: oEmbed 1.0 discovery for ksqtx.com URLs. Verified live anonymously on 2026-08-23 — provider_name "KSQ Therapeutics",
provider_url https://ksqtx.com.
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://ksqtx.com/wp-json
tags:
- oembed
tags_raw:
- oembed
x-origin: platform-default
properties:
- type: OpenAPI
url: openapi/ksq-therapeutics-oembed-api-openapi.yml
- type: Authentication
url: authentication/ksq-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/ksq-therapeutics-problem-types.yml
- type: Conventions
url: conventions/ksq-therapeutics-conventions.yml
- type: DataModel
url: data-model/ksq-therapeutics-data-model.yml
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Website
url: https://ksqtx.com/
- type: About
url: https://ksqtx.com/about/
- type: Platform
url: https://ksqtx.com/platform/
- type: Pipeline
url: https://ksqtx.com/pipeline/
- type: Partners
url: https://ksqtx.com/partners/
- type: Blog
url: https://ksqtx.com/news/
- type: BlogRSS
url: https://ksqtx.com/feed/
- type: News
url: https://ksqtx.com/press-releases/
- type: Careers
url: https://ksqtx.com/careers/
- type: Support
url: https://ksqtx.com/contact-us/
- type: PatientResources
url: https://ksqtx.com/eap/
- type: GitHubOrganization
url: https://github.com/ksqtx
- type: SourceCode
url: https://github.com/ksqtx/TRACE
- type: LinkedIn
url: https://www.linkedin.com/company/10414448/
- type: Twitter
url: https://twitter.com/KSQ_TX
- type: SecondaryMarket
url: https://forgeglobal.com/ksq-therapeutics_stock/
- type: Authentication
url: authentication/ksq-therapeutics-authentication.yml
- type: Conventions
url: conventions/ksq-therapeutics-conventions.yml
- type: Conformance
url: conformance/ksq-therapeutics-conformance.yml
- type: ErrorCatalog
url: errors/ksq-therapeutics-problem-types.yml
- type: Lifecycle
url: lifecycle/ksq-therapeutics-lifecycle.yml
- type: DataModel
url: data-model/ksq-therapeutics-data-model.yml
- type: Overlay
url: overlays/ksq-therapeutics-content-overlay.yaml
- type: DomainSecurity
url: security/ksq-therapeutics-domain-security.yml
- type: LLMsTxt
url: llms/ksq-therapeutics-llms.txt
- type: Packages
url: packages/ksq-therapeutics-packages.yml
- type: CLI
url: cli/ksq-therapeutics-cli.yml
- type: Plans
url: plans/ksq-therapeutics-plans-pricing.yml
- type: RateLimits
url: rate-limits/ksq-therapeutics-rate-limits.yml
- type: AgentSkill
url: skills/_index.yml
x-enrichment:
date: '2026-08-23'
status: enriched
artifacts_added: 29
pass: local-v1
x-coverage:
state: covered
reason: platform-surface-only
detail: KSQ Therapeutics is a clinical-stage biotech with no developer program and no product API — /openapi.json, /swagger.json,
/api-docs, /docs, /redoc and /graphql all 404 on ksqtx.com, every /.well-known/ path 404s including both agent-card locations,
and api./docs./developer.ksqtx.com resolve only to a wildcard GoDaddy parking address with no matching TLS certificate
— but the corporate WordPress site serves a live, anonymously readable REST content API at https://ksqtx.com/wp-json (349
routes, 9 namespaces) plus an All in One SEO generated /llms.txt, and the company publishes first-party open-source bioinformatics
code at github.com/ksqtx; that is what this profile captures.
evidence:
- url: https://ksqtx.com/openapi.json
status: 404
- url: https://ksqtx.com/.well-known/agent-card.json
status: 404
- url: https://ksqtx.com/.well-known/api-catalog
status: 404
- url: https://ksqtx.com/wp-json
status: 200
- url: https://ksqtx.com/wp-json/wp/v2/press_release
status: 200
- url: https://ksqtx.com/wp-json/mcp
status: 404
- url: https://ksqtx.com/llms.txt
status: 200
- url: https://github.com/ksqtx
status: 200
checked: '2026-08-23'
Every provider here is available over the APIs.io API and to AI agents over MCP.
MCP server
One button, every client — Claude, Cursor, VS Code and the rest.
https://apis.io/mcp
Tools for providers
9 MCP tools reach this
find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.
All 92 tools
Call it yourself
curl for this page
This provider
curl "https://apis.io/api/v1/providers/ksq-therapeutics"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/ksq-therapeutics/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/ksq-therapeutics/evidence"
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no email required.
A second provider on the same verified email joins the account you already have.